Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 10(1): 8724, 2020 05 26.
Article in English | MEDLINE | ID: mdl-32457420

ABSTRACT

Lassa virus (LASV) is the causative agent of Lassa fever (LF), an often-fatal hemorrhagic disease. LF is endemic in Nigeria, Sierra Leone and other West African countries. Diagnosis of LASV infection is challenged by the genetic diversity of the virus, which is greatest in Nigeria. The ReLASV Pan-Lassa Antigen Rapid Test (Pan-Lassa RDT) is a point-of-care, in vitro diagnostic test that utilizes a mixture of polyclonal antibodies raised against recombinant nucleoproteins of representative strains from the three most prevalent LASV lineages (II, III and IV). We compared the performance of the Pan-LASV RDT to available quantitative PCR (qPCR) assays during the 2018 LF outbreak in Nigeria. For patients with acute LF (RDT positive, IgG/IgM negative) during initial screening, RDT performance was 83.3% sensitivity and 92.8% specificity when compared to composite results of two qPCR assays. 100% of samples that gave Ct values below 22 on both qPCR assays were positive on the Pan-Lassa RDT. There were significantly elevated case fatality rates and elevated liver transaminase levels in subjects whose samples were RDT positive compared to RDT negative.


Subject(s)
Antibodies, Viral/metabolism , Diagnostic Tests, Routine/methods , Lassa Fever/diagnosis , Lassa virus/isolation & purification , RNA, Viral/genetics , Adult , Antigens, Viral/immunology , Disease Outbreaks , Female , Humans , Lassa virus/genetics , Lassa virus/immunology , Male , Middle Aged , Nigeria , Point-of-Care Systems , Sensitivity and Specificity , Sequence Analysis, RNA , Young Adult
2.
N Engl J Med ; 379(18): 1745-1753, 2018 11 01.
Article in English | MEDLINE | ID: mdl-30332564

ABSTRACT

During 2018, an unusual increase in Lassa fever cases occurred in Nigeria, raising concern among national and international public health agencies. We analyzed 220 Lassa virus genomes from infected patients, including 129 from the 2017-2018 transmission season, to understand the viral populations underpinning the increase. A total of 14 initial genomes from 2018 samples were generated at Redeemer's University in Nigeria, and the findings were shared with the Nigerian Center for Disease Control in real time. We found that the increase in cases was not attributable to a particular Lassa virus strain or sustained by human-to-human transmission. Instead, the data were consistent with ongoing cross-species transmission from local rodent populations. Phylogenetic analysis also revealed extensive viral diversity that was structured according to geography, with major rivers appearing to act as barriers to migration of the rodent reservoir.


Subject(s)
Genome, Viral , Lassa Fever/virology , Lassa virus/genetics , RNA, Viral/analysis , Adolescent , Adult , Animals , Bayes Theorem , Disease Reservoirs , Female , Genetic Variation , Humans , Lassa Fever/epidemiology , Lassa Fever/transmission , Male , Markov Chains , Middle Aged , Nigeria/epidemiology , Phylogeny , Phylogeography , Rodentia , Sequence Analysis, RNA , Zoonoses/transmission
3.
PLoS Negl Trop Dis ; 9(3): e0003631, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25781465

ABSTRACT

Next-generation sequencing (NGS) has the potential to transform the discovery of viruses causing unexplained acute febrile illness (UAFI) because it does not depend on culturing the pathogen or a priori knowledge of the pathogen's nucleic acid sequence. More generally, it has the potential to elucidate the complete human virome, including viruses that cause no overt symptoms of disease, but may have unrecognized immunological or developmental consequences. We have used NGS to identify RNA viruses in the blood of 195 patients with UAFI and compared them with those found in 328 apparently healthy (i.e., no overt signs of illness) control individuals, all from communities in southeastern Nigeria. Among UAFI patients, we identified the presence of nucleic acids from several well-characterized pathogenic viruses, such as HIV-1, hepatitis, and Lassa virus. In our cohort of healthy individuals, however, we detected the nucleic acids of two novel rhabdoviruses. These viruses, which we call Ekpoma virus-1 (EKV-1) and Ekpoma virus-2 (EKV-2), are highly divergent, with little identity to each other or other known viruses. The most closely related rhabdoviruses are members of the genus Tibrovirus and Bas-Congo virus (BASV), which was recently identified in an individual with symptoms resembling hemorrhagic fever. Furthermore, by conducting a serosurvey of our study cohort, we find evidence for remarkably high exposure rates to the identified rhabdoviruses. The recent discoveries of novel rhabdoviruses by multiple research groups suggest that human infection with rhabdoviruses might be common. While the prevalence and clinical significance of these viruses are currently unknown, these viruses could have previously unrecognized impacts on human health; further research to understand the immunological and developmental impact of these viruses should be explored. More generally, the identification of similar novel viruses in individuals with and without overt symptoms of disease highlights the need for a broader understanding of the human virome as efforts for viral detection and discovery advance.


Subject(s)
RNA, Viral/genetics , Rhabdoviridae Infections/diagnosis , Rhabdoviridae Infections/virology , Rhabdoviridae/isolation & purification , Adult , Africa, Western/epidemiology , Base Sequence , Case-Control Studies , Female , High-Throughput Nucleotide Sequencing , Humans , Male , Nigeria/epidemiology , RNA Viruses/classification , RNA Viruses/genetics , RNA Viruses/isolation & purification , Rhabdoviridae/classification , Rhabdoviridae/genetics , Rhabdoviridae Infections/epidemiology , Sequence Analysis, RNA
SELECTION OF CITATIONS
SEARCH DETAIL
...